Related Experiment Video
Updated: May 24, 2025
05:34
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
433
End Stage Kidney Disease Treatment Options
Rachael Buening1,2,3, Sheila Deziel4,5,6
1Lead Nephrology Clinical Specialist, Dialyze Direct, Chicago, IL.
Summary
Patients with end-stage kidney disease must choose a renal replacement therapy. Early, multidisciplinary discussions about treatment options like transplant, dialysis, and supportive care are crucial for informed decision-making.
Area of Science:
- Nephrology
- Renal Medicine
- Patient Care
Background:
- Chronic kidney disease (CKD) progresses to end-stage kidney disease (ESKD).
- ESKD necessitates renal replacement therapy for survival.
- Patients face critical treatment decisions upon reaching ESKD.
Purpose of the Study:
- To emphasize the importance of early patient-provider discussions regarding ESKD treatment options.
- To highlight the need for a multidisciplinary team approach in managing ESKD.
- To outline available treatment modalities for patients with kidney failure.
Main Methods:
- This is a conceptual overview, not a research study.
- Literature review of current ESKD treatment guidelines and patient management strategies.
- Analysis of the components of effective patient-centered care in nephrology.
Main Results:
- Timely initiation of treatment option discussions improves patient outcomes.
- Multidisciplinary team involvement ensures comprehensive patient support.
- A range of therapeutic options exist, including transplantation, dialysis, and conservative management.
Conclusions:
- Early and comprehensive discussions about renal replacement therapies are vital for patients with progressing CKD.
- Integrating the multidisciplinary team into the decision-making process enhances patient care.
- Informed choices among transplant, peritoneal dialysis, hemodialysis, and supportive care empower patients facing kidney failure.
Keywords:
chronic kidney diseasediabetesend stage kidney diseasehemodialysiskidney replacement therapytransplantationtreatment optionsMore Related Videos
08:505/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
Published on: July 3, 2013
23.5K
09:00Microdissection of Primary Renal Tissue Segments and Incorporation with Novel Scaffold-free Construct Technology
Published on: March 27, 2018
7.4K
Related Concept Videos
01:27Dialysis
247
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
247
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
363
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
363
01:22Heart Failure Drugs: Diuretics
324
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
324
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
123
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
123
01:45Kidney Structure
68.5K
The kidneys are two large bean-shaped organs located in the upper abdomen. They filter the blood several times a day to remove toxins and rebalance water and electrolytes of the circulatory system via the renal veins. The kidneys receive blood directly from the heart via the renal arteries. These arteries enter the kidney at the hilum, the concave surface of the bean, where they branch and divide into smaller vessels and capillaries.
68.5K
01:11Renal Failure: Dose Adjustments
54
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
54